{
  "ptid_time": "098_S_4215_2011-09-12",
  "img_path": "/data/qiuhui/data/adni/images/098_S_4215/2011-09-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 55,409 mm³, 17.9% above the reference mean. With a Z-score of 0.52 (69.8th percentile), this represents normal volume ; hippocampal volume measures 6,098 mm³, 12.5% below the reference mean. With a Z-score of -1.08 (14.0th percentile), this represents mild atrophy; whole brain volume measures 1,067,490 mm³, 3.7% above the reference mean. With a Z-score of 0.49 (68.7th percentile), this represents normal volume . ",
  "text_data": "Age is 81.6 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Malignancy; Major Surgical Procedures. MMSE: 26.0. MoCA: 25.0. Logical Memory: 0.0. Laboratory findings: Total Bilirubin: 0.90 (significant elevated); Creatinine (Rate Blanked): 1.40 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.70 SUVR (profound elevated); Amyloid beta: 576.40 pg/mL (mild reduced); Total tau: 257.90 pg/mL (normal ); Phosphorylated tau: 27.32 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows mild atrophy (Z-score -1.08, 14th percentile), which is concerning for early neurodegeneration, while ventricular and whole brain volumes are normal. Cognitive scores (MMSE 26, MoCA 25) are borderline but still within normal limits for age. Biomarkers indicate amyloid pathology (Aβ mildly reduced, AV45 profoundly elevated) but normal tau levels, suggesting early Alzheimer's pathology without significant neuronal injury.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are borderline, and while hippocampal atrophy and amyloid burden suggest early AD, clinical symptoms are not yet severe enough for dementia.)",
  "timestamp": "2025-07-26T10:47:56.700781"
}